{"transactions":[{"id":934511,"issuer":{"id":5577,"kind":"organization","name":"GALECTIN THERAPEUTICS INC"},"owners":[{"id":69097,"kind":"person","name":"Zordani Richard A. Jr.","position":1,"cik":"0001827180","reported_name":"Zordani Richard A. Jr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2026-01-21T21:50:50.000Z","date":"2026-01-16","kind":"grant","planned":false,"acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The stock options were issued pursuant to the Galectin Therapeutics, Inc. 2019 Omnibus Equity Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest 100% on December 31, 2026."}],"balance_after":60000,"derivative":{"exercise_price":3.04,"expiration_date":"2036-01-16","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001133416-26-000040","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1133416/000113341626000040/form4.xml","form_type":"4"}},{"id":1294692,"issuer":{"id":5577,"kind":"organization","name":"GALECTIN THERAPEUTICS INC"},"owners":[{"id":69097,"kind":"person","name":"Zordani Richard A. Jr.","position":1,"cik":"0001827180","reported_name":"Zordani Richard A. Jr.","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2025-01-27T21:09:56.000Z","date":"2025-01-23","kind":"grant","planned":false,"acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The stock options were issued pursuant to the Galectin Therapeutics, Inc. 2019 Omnibus Equity Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest 100% on December 31, 2025."}],"balance_after":60000,"derivative":{"exercise_price":1.23,"expiration_date":"2035-01-23","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001133416-25-000024","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1133416/000113341625000024/form4.xml","form_type":"4"}},{"id":1322063,"issuer":{"id":5577,"kind":"organization","name":"GALECTIN THERAPEUTICS INC"},"owners":[{"id":69097,"kind":"person","name":"Zordani Richard A. Jr.","position":1,"cik":"0001827180","reported_name":"Zordani Richard A. Jr.","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-12-26T13:16:12.000Z","date":"2024-12-24","kind":"purchase","planned":false,"acquired":true,"shares":10000,"price":0.8164,"value":8164.0,"ownership":{"direct":true},"balance_after":42083,"source":{"system":"sec-edgar","filing":"0001133416-24-000066","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1133416/000113341624000066/form4.xml","form_type":"4"}},{"id":1423476,"issuer":{"id":5577,"kind":"organization","name":"GALECTIN THERAPEUTICS INC"},"owners":[{"id":69097,"kind":"person","name":"Zordani Richard A. Jr.","position":1,"cik":"0001827180","reported_name":"Zordani Richard A. Jr.","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-08-26T12:08:18.000Z","date":"2024-08-23","kind":"purchase","planned":false,"acquired":true,"shares":1759,"price":2.3,"value":4045.7,"ownership":{"direct":true},"balance_after":32083,"source":{"system":"sec-edgar","filing":"0001133416-24-000054","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1133416/000113341624000054/form4.xml","form_type":"4"}},{"id":1423475,"issuer":{"id":5577,"kind":"organization","name":"GALECTIN THERAPEUTICS INC"},"owners":[{"id":69097,"kind":"person","name":"Zordani Richard A. Jr.","position":1,"cik":"0001827180","reported_name":"Zordani Richard A. Jr.","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-08-26T12:08:18.000Z","date":"2024-08-22","kind":"purchase","planned":false,"acquired":true,"shares":741,"price":2.3,"value":1704.3,"ownership":{"direct":true},"balance_after":30324,"source":{"system":"sec-edgar","filing":"0001133416-24-000054","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1133416/000113341624000054/form4.xml","form_type":"4"}},{"id":1423474,"issuer":{"id":5577,"kind":"organization","name":"GALECTIN THERAPEUTICS INC"},"owners":[{"id":69097,"kind":"person","name":"Zordani Richard A. Jr.","position":1,"cik":"0001827180","reported_name":"Zordani Richard A. Jr.","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-08-26T12:08:18.000Z","date":"2024-08-23","kind":"purchase","planned":false,"acquired":true,"shares":1000,"price":2.3,"value":2300.0,"ownership":{"direct":false,"nature":"as UTMA custodian for a minor child"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These shares are held of record by the Reporting Person as custodian for a minor child under the Uniform Transfer to Minors Act. The Reporting Person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purpose of Section 16 or for any other purpose."}],"balance_after":2000,"source":{"system":"sec-edgar","filing":"0001133416-24-000054","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1133416/000113341624000054/form4.xml","form_type":"4"}},{"id":1532979,"issuer":{"id":5577,"kind":"organization","name":"GALECTIN THERAPEUTICS INC"},"owners":[{"id":69097,"kind":"person","name":"Zordani Richard A. Jr.","position":1,"cik":"0001827180","reported_name":"Zordani Richard A. Jr.","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-04-30T18:14:40.000Z","date":"2024-04-30","kind":"purchase","planned":false,"acquired":true,"shares":1000,"price":3.52,"value":3520.0,"ownership":{"direct":false,"nature":"as UTMA custodian for a minor child"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These shares are held of record by the Reporting Person as custodian for a minor child under the Uniform Transfer to Minors Act. The Reporting Person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purpose of Section 16 or for any other purpose."}],"balance_after":1000,"source":{"system":"sec-edgar","filing":"0001133416-24-000042","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1133416/000113341624000042/form4.xml","form_type":"4"}},{"id":1655591,"issuer":{"id":5577,"kind":"organization","name":"GALECTIN THERAPEUTICS INC"},"owners":[{"id":69097,"kind":"person","name":"Zordani Richard A. Jr.","position":1,"cik":"0001827180","reported_name":"Zordani Richard A. Jr.","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2024-02-07T21:55:59.000Z","date":"2024-01-24","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The stock options were issued pursuant to the Galectin Therapeutics, Inc. 2019 Omnibus Equity Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest 100% on December 31, 2024."}],"balance_after":50000,"derivative":{"exercise_price":1.72,"expiration_date":"2034-01-24","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001133416-24-000028","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1133416/000113341624000028/form4.xml","form_type":"4"}},{"id":2042460,"issuer":{"id":5577,"kind":"organization","name":"GALECTIN THERAPEUTICS INC"},"owners":[{"id":69097,"kind":"person","name":"Zordani Richard A. Jr.","position":1,"cik":"0001827180","reported_name":"Zordani Richard A. Jr.","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2023-01-30T21:55:28.000Z","date":"2023-01-26","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The stock options were issued pursuant to the Galectin Therapeutics, Inc. 2019 Omnibus Equity Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest 100% on December 31, 2023."}],"balance_after":40000,"derivative":{"exercise_price":1.11,"expiration_date":"2033-01-26","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001133416-23-000032","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1133416/000113341623000032/form4.xml","form_type":"4"}},{"id":2200419,"issuer":{"id":5577,"kind":"organization","name":"GALECTIN THERAPEUTICS INC"},"owners":[{"id":69097,"kind":"person","name":"Zordani Richard A. Jr.","position":1,"cik":"0001827180","reported_name":"Zordani Richard A. Jr.","relationship":{"director":true}}],"security":"Common Stock","published_at":"2022-07-29T13:11:59.000Z","date":"2022-07-28","kind":"purchase","acquired":true,"shares":5000,"price":2.5,"value":12500.0,"ownership":{"direct":true},"balance_after":29583,"source":{"system":"sec-edgar","filing":"0001133416-22-000073","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1133416/000113341622000073/form4.xml","form_type":"4"}},{"id":2308938,"issuer":{"id":5577,"kind":"organization","name":"GALECTIN THERAPEUTICS INC"},"owners":[{"id":69097,"kind":"person","name":"Zordani Richard A. Jr.","position":1,"cik":"0001827180","reported_name":"Zordani Richard A. Jr.","relationship":{"director":true}}],"security":"Common Stock","published_at":"2022-04-04T18:58:23.000Z","date":"2022-04-04","kind":"purchase","acquired":true,"shares":5000,"price":1.605,"value":8025.0,"ownership":{"direct":true},"balance_after":24583,"source":{"system":"sec-edgar","filing":"0001133416-22-000053","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1133416/000113341622000053/form4.xml","form_type":"4"}},{"id":2426932,"issuer":{"id":5577,"kind":"organization","name":"GALECTIN THERAPEUTICS INC"},"owners":[{"id":69097,"kind":"person","name":"Zordani Richard A. Jr.","position":1,"cik":"0001827180","reported_name":"Zordani Richard A. Jr.","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2022-01-25T21:26:44.000Z","date":"2022-01-24","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The options were issued pursuant to the Galectin Therapeutics Inc. 2019 Omnibus Equity Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest 100% on December 31, 2022."}],"balance_after":40000,"derivative":{"exercise_price":1.98,"expiration_date":"2032-01-24","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001133416-22-000024","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1133416/000113341622000024/form4.xml","form_type":"4"}},{"id":2434027,"issuer":{"id":5577,"kind":"organization","name":"GALECTIN THERAPEUTICS INC"},"owners":[{"id":69097,"kind":"person","name":"Zordani Richard A. Jr.","position":1,"cik":"0001827180","reported_name":"Zordani Richard A. Jr.","relationship":{"director":true}}],"security":"Common Stock","published_at":"2022-01-18T13:54:55.000Z","date":"2022-01-14","kind":"purchase","acquired":true,"shares":5000,"price":2.02,"value":10100.0,"ownership":{"direct":true},"balance_after":19583,"source":{"system":"sec-edgar","filing":"0001133416-22-000006","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1133416/000113341622000006/form4.xml","form_type":"4"}},{"id":2766860,"issuer":{"id":5577,"kind":"organization","name":"GALECTIN THERAPEUTICS INC"},"owners":[{"id":69097,"kind":"person","name":"Zordani Richard A. Jr.","position":1,"cik":"0001827180","reported_name":"Zordani Richard A. Jr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2021-03-31T20:40:29.000Z","date":"2021-03-25","kind":"grant","acquired":true,"shares":70000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The options were issued pursuant to the Galectin Therapeutics Inc. 2019 Omnibus Equity Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Such options vest when (i) the Company has received the interim results of its NAVIGATE clinical trial and (ii) makes a public announcement that it has received the interim results."}],"balance_after":70000,"derivative":{"exercise_price":2.11,"expiration_date":"2031-03-25","underlying":"Common Stock","underlying_shares":70000},"source":{"system":"sec-edgar","filing":"0000899243-21-014210","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1133416/000089924321014210/doc4.xml","form_type":"4"}},{"id":2766859,"issuer":{"id":5577,"kind":"organization","name":"GALECTIN THERAPEUTICS INC"},"owners":[{"id":69097,"kind":"person","name":"Zordani Richard A. Jr.","position":1,"cik":"0001827180","reported_name":"Zordani Richard A. Jr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2021-03-31T20:40:29.000Z","date":"2021-03-25","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The options were issued pursuant to the Galectin Therapeutics Inc. 2019 Omnibus Equity Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Such options vest 100% on March 31, 2022."}],"balance_after":40000,"derivative":{"exercise_price":2.11,"expiration_date":"2031-03-25","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0000899243-21-014210","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1133416/000089924321014210/doc4.xml","form_type":"4"}}]}